Stepan Company Reports Q3 2025 Results with Decline in Net Income Despite Revenue Growth

Stepan Company reported its financial results for the third quarter and the first nine months of 2025, revealing a decline in net income and operating income compared to the previous year. For the nine months ended September 30, 2025, net income was $41.9 million, or $1.83 per diluted share, down from $47.0 million, or $2.05 per diluted share, in the same period of 2024. The company’s adjusted net income for the same period was $42.2 million, or $1.84 per diluted share, compared to $47.7 million, or $2.08 per diluted share, in 2024. Total revenue for the first nine months increased by 7% to $1.78 billion, driven primarily by higher average selling prices, which contributed $103.7 million to the revenue growth.

In the third quarter alone, Stepan's net sales rose by 8% to $590.3 million, compared to $546.8 million in the prior year. This increase was attributed to a combination of higher average selling prices and a slight increase in sales volume. However, operating income for the quarter decreased by 9% to $21.8 million, reflecting challenges in the Surfactants and Polymers segments, which saw declines in operating income of 40% and 8%, respectively. The Specialty Products segment, however, reported a significant increase in operating income, up 158% year-over-year.

The company also noted strategic developments, including the issuance of $75 million in senior unsecured notes to support its operations and capital expenditures. Stepan's capital expenditures for the first nine months of 2025 totaled $87.9 million, with expectations to reach between $118 million and $123 million for the full year. Additionally, the company is in the process of selling its manufacturing assets in the Philippines, which are valued at approximately $8.5 million.

Operationally, Stepan's total assets increased to $2.43 billion as of September 30, 2025, up from $2.30 billion at the end of 2024. The company reported a cash and cash equivalents balance of $118.5 million, reflecting a $18.9 million increase since the beginning of the year. The company’s debt also rose to $655.5 million, primarily due to the new note issuance, while the net debt ratio improved slightly to 30.1%. Looking ahead, Stepan Company anticipates continued challenges in the market but remains focused on leveraging its operational strengths and strategic initiatives to drive future growth.